Affymax Announces Upcoming Webcasts and Conference Participation
24th Annual Piper Jaffray Health Care Conference
Tuesday, November 27, 2012 in New York City
10:00 a.m. Eastern Time (7:00 a.m. Pacific Time)
2012 Deutsche Bank dbAccess BioFEST
Monday, December 3, 2012 in Boston
2:15 p.m. Eastern Time (11:15 a.m. Pacific Time)
A live webcast of the presentations will be available on the investors section of the Company's website at http://www.investors.affymax.com/events.cfm. A replay will also be available for 30 days following the presentations.
About Affymax, Inc.
Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California. Affymax's mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses.
The company's first marketed product, OMONTYS® (peginesatide) Injection, was approved by the U.S. Food and Drug Administration (FDA) in March 2012. For additional information, please visit www.affymax.com.
Alexandra Santos, 650-812-8961
Associate Director, Corporate Communications
KEYWORDS: United States North America California Massachusetts New York
The article Affymax Announces Upcoming Webcasts and Conference Participation originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.